Hainan Poly Pharm: An indicative notice on the risk of not being able to disclose the 2023 Annual Report and the 2024 First Quarter Report within the statutory period

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.